| scholarly article | Q13442814 |
| P2093 | author name string | C. A. Kraaijeveld | |
| H. Snippe | |||
| M. Harmsen | |||
| A. Snijders | |||
| B. J. Benaissa-Trouw | |||
| I. M. Fernández | |||
| P2860 | cites work | Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus | Q27486929 |
| Developments in foot-and-mouth disease vaccines | Q36395476 | ||
| Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities | Q36895841 | ||
| The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides | Q39340678 | ||
| Adjuvants | Q39692526 | ||
| An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity | Q39752133 | ||
| Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication | Q41658888 | ||
| Genome sequences of a mouse-avirulent and a mouse-virulent strain of Ross River virus | Q42648653 | ||
| Nucleotide sequence of cdna coding for Semliki Forest virus membrane glycoproteins | Q44522466 | ||
| The Virulence of Original and Derived Strains of Semliki Forest Virus for Mice, Guinea-pigs and Rabbits | Q44546765 | ||
| Regulation of Isotype Immunoglobulin Production by Adjuvants in Vivo | Q44650166 | ||
| Polarity of immunogens: implications for vaccine design | Q44693960 | ||
| Murine IgG subclass responses to herpes simplex virus type 1 and polypeptides | Q45841703 | ||
| Prophylaxis and therapy of virulent encephalomyocarditis virus infection in mice by monoclonal antibodies. Brief report | Q45841943 | ||
| The immunoglobulin G subclass responses of mice to influenza A virus: the effect of mouse strain, and the neutralizing abilities of individual protein A-purified subclass antibodies | Q45843111 | ||
| Location of a major antigenic site involved in Ross River virus neutralization | Q45847743 | ||
| Identification of linear epitopes on Semliki Forest virus E2 membrane protein and their effectiveness as a synthetic peptide vaccine | Q45859885 | ||
| Immunogenicity and vaccine efficacy of synthetic peptides containing Semliki Forest virus B and T cell epitopes | Q45872469 | ||
| A delayed-type hypersensitivity-inducing T-cell epitope of Semliki Forest virus mediates effective T-helper activity for antibody production | Q45881453 | ||
| Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody | Q47431228 | ||
| Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis | Q59070308 | ||
| PEROXIDASE-LABELED ANTIBODY A NEW METHOD OF CONJUGATION | Q59383601 | ||
| Immunological adjuvants: Desirable properties and side-effects | Q67915374 | ||
| Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex | Q68181960 | ||
| Antibody-mediated clearance of alphavirus infection from neurons | Q68262671 | ||
| Orientation of epitopes influences the immunogenicity of synthetic peptide dimers | Q69052770 | ||
| Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies | Q69090852 | ||
| Competition binding assay in cell culture for identification of epitopes on enveloped and naked viruses | Q69098228 | ||
| Adjuvants influence the immunoglobin subclass distribution of immune responses in vivo | Q70472898 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Semliki Forest virus | Q428413 |
| P304 | page(s) | 5843-5848 | |
| P577 | publication date | 1993-10-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus | |
| P478 | volume | 67 |
| Q21266599 | Bcipep: a database of B-cell epitopes |
| Q45754165 | Epitope polarity and adjuvants influence the fine specificity of the humoral response against Semliki Forest virus specific peptide vaccines |
| Q33815412 | Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein |
| Q45753083 | Induction of HIV-1 IIIb neutralizing antibodies in BALB/c mice by a chimaeric peptide consisting of a T-helper cell epitope of Semliki Forest virus and a B-cell epitope of HIV. |
| Q43522758 | Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants |
| Q34125960 | Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens. |
| Q51837773 | Rapid Monoclonal Antibody Generation Via Dendritic Cell TargetingIn Vivo |
| Q40056277 | Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines. |
| Q40829552 | The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein |
| Q39315413 | The potential of immunization with synthetic peptides to overcome the immunosuppressive effect of maternal anti-measles virus antibodies in young mice. |
| Q74261407 | The specificity of antibodies raised against a T cell peptide is influenced by peptide amidation |
Search more.